ID   CPGHi006-A
AC   CVCL_B5QR
AS   CVCL_B6XG
SY   PLAFMCi006-A
DR   BioSamples; SAMEA12123062
DR   hPSCreg; CPGHi006-A
DR   Wikidata; Q111733134
RX   PubMed=35091308;
CC   From: Chinese PLA Institute of Otolaryngology, Chinese PLA General Hospital; Beijing; China.
CC   Population: Chinese.
CC   Sequence variation: Mutation; HGNC; 9009; PKD2; Unexplicit; Ex3-15del; Zygosity=Heterozygous (PubMed=35091308).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C84578; Autosomal dominant polycystic kidney disease
DI   ORDO; Orphanet_730; Autosomal dominant polycystic kidney disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   42Y
CA   Induced pluripotent stem cell
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
RX   PubMed=35091308; DOI=10.1016/j.scr.2022.102681;
RA   Ma Y.-X., Shang S.-L., Shi M.-H., Yang Y.-Z., Li Q.-G., Bai X.-Y.;
RT   "Establishment of the induced pluripotent stem cell line PLAFMCi006-A
RT   from peripheral blood mononuclear cells of polycystic kidney disease
RT   patients with PKD2 gene mutation.";
RL   Stem Cell Res. 60:102681-102681(2022).
//